REQUEST A DEMO
Total
USD $0.00
Search more companies

Imetrab Instituto de Medicina del Trabajo CIA Ltda (Ecuador)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Imetrab Instituto de Medicina del Trabajo CIA Ltda Profile Updated: February 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Imetrab Instituto de Medicina del Trabajo CIA Ltda is an enterprise located in Ecuador, with the main office in Conocoto. It operates in the Research and Development in the Physical, Engineering, and Life Sciences industry. The enterprise was incorporated on February 10, 2012. The total number of employees is currently 4 (2024). In 2024, the company reported a net sales revenue increase of 30.53%. Its total assets grew by 19.11% over the same period.

Headquarters
Abdon Calderon E-804
Conocoto; Pichincha;

Contact Details: Purchase the Imetrab Instituto de Medicina del Trabajo CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Imetrab Instituto de Medicina del Trabajo CIA Ltda report to view the information.
Registered Capital:
Purchase the Imetrab Instituto de Medicina del Trabajo CIA Ltda report to view the information.
Financial Auditors:
Purchase the Imetrab Instituto de Medicina del Trabajo CIA Ltda report to view the information.
Incorporation Date:
February 10, 2012
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
49.99%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Imetrab Instituto de Medicina del Trabajo CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
30.53%
Total operating revenue
30.53%
Operating profit (EBIT)
N/A
EBITDA
38.95%
Net Profit (Loss) for the Period
N/A
Total Assets
19.11%
Total Equity
3.89%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?